Loading clinical trials...

Fitness Integrative Training for Pediatric Rheumatology Disorders | Clinical Trials | Clareo Health

COMPLETEDNA

Fitness Integrative Training for Pediatric Rheumatology Disorders

Fitness Integrative Training for Pediatric Rheumatology Disorders (FIT Teens II): a Pilot Feasibility Study

NCT06556992•Children's Hospital Medical Center, Cincinnati

Summary

This study evaluates the feasibility of the Fitness Integrative Training program for Teens (FIT Teens 2), a combined cognitive behavioral therapy and neuromuscular exercise training program in patients with pediatric rheumatic diseases and/or joint hypermobility.

Eligibility

Age

10 - 19 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Pediatric rheumatic diseases (PRD) or joint hypermobility (JH) diagnosed by a pediatric rheumatologist or pain physician.
•Initial diagnosis ≥ 3 months ago
•Ages 10-19 years, inclusive
•Ongoing symptoms of musculoskeletal pain and/or fatigue for at least 3 months
•Functional Disability Index (FDI) Score ≥ 13 indicating at least moderate disability.
•Child has written and spoken proficiency in English and parent has written and spoken proficiency in English or Spanish (will have a certified bilingual provider or interpreter available)

Exclusion Criteria

•Untreated major psychiatric diagnoses (e.g., major depression, bipolar disorder, psychoses) or documented developmental delay.
•Any other medical condition determined by their physician to be a contraindication for exercise.
•Childhood Myositis Assessment Scale (CMAS) ≤ 30

Locations (1)

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

Key Dates

Start Date

September 24, 2024

Primary Completion Date

July 2, 2025

Completion Date

July 2, 2025

Last Updated

August 28, 2025

Enrollment

ACTUAL participants

Conditions

Juvenile Idiopathic ArthritisSystemic Lupus Erythematosus of ChildhoodJoint HypermobilityJuvenile Dermatomyositis

Interventions

FIT Teens

BEHAVIORAL

Dynamic Gait Index as a Functional Gait Assessment Measure in Children With JIA

NCT06870045

Juvenile Idiopathic ArthritisChildhood Rheumatic Disease

View study

RECRUITING

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

NCT04902807

Autoimmune Lymphoproliferative SyndromeAutoimmune Cytopenia+18 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 28, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Fitness Integrative Training for Pediatric Rheumatology Disorders

Inclusion Criteria

Exclusion Criteria

Dynamic Gait Index as a Functional Gait Assessment Measure in Children With JIA

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions

Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults

Interferon Pathway Activation in Monogenic and Nonmonogenic Forms of Pediatric SLE

Clinical, Laboratory and Ultrasound Stratification of Patients With Juvenile Idiopathic Arthritis